AIM news https://www.accesswire.com/603567/AIM-ImmunoTech-Inc-Decreases-SARS-CoV-2-Infectious-Viral-Yields-by-90-Using-New-In-Vitro-Model-Supports-Further-Testing-of-Ampligen-as-an-Intranasal-Prophylactic-to-Prevent-COVID-19